Tianda Pharmaceuticals Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tianda Pharmaceuticals Ltd with three other
pharmaceutical manufacturers in Asia:
sales of 3.91 billion Indian Rupees [US$54.24 million]
Novartis India Limited
(4.91 billion Indian Rupees [US$68.01 million]
of which 100%
was Pharamaceutical Business), and
Fermenta Biotech Ltd
based in India
(4.05 billion Indian Rupees [US$56.09 million]
of which 96%
was Bulk Drugs/Chemicals).
During the year ended March of 2019, sales at
Tianda Pharmaceuticals Ltd were HK$527.00 million (US$67.32 million).
increase of 45.8%
versus 2018, when the company's sales were HK$361.55 million.
This was the fourth straight year of sales growth at Tianda Pharmaceuticals Ltd.